Upload
edmund-tom-ivy-conan
View
219
Download
0
Embed Size (px)
Citation preview
7/30/2019 1 Regulation of Enzymic Activity
1/44
Regulation of enzymic
activity.Inhibition. Activation.
7/30/2019 1 Regulation of Enzymic Activity
2/44
Activator groups
Activators may act on
Active site of the enzyme or onAllosteric site (allosteric
activators)
7/30/2019 1 Regulation of Enzymic Activity
3/44
Activation of enzymes.
One group of activators is made upof compounds affecting the activecenter region of an enzyme.
This group includes
1) substrates and
2) enzyme cofactors (metalions, coenzymes and prostheticgroups)
7/30/2019 1 Regulation of Enzymic Activity
4/44
Activation by metal ions
Metal ions can1) form part of the catalytic center
(ex. metals with variable valence (Fe+2) in
cytochromes electron transport).
2) the metal links with the substrate rather than
with the enzyme forming thereby a
metallosubstrate complex whichis more advantageous for the enzyme activity
(ex.Mg+2 or Mn+2 form complexes with ATP
for creatin kinase and ATPase).
7/30/2019 1 Regulation of Enzymic Activity
5/44
Activation by metal ions
3) metal ions facilitate the bindingof a substrate to the enzyme
active center or coenzyme to theapoenzyme by forming a kind ofbridge bonds.
4) metal ions can stabilize theconformation of apoenzyme(protein part of enzyme).
7/30/2019 1 Regulation of Enzymic Activity
6/44
Activation by coenzymes
The specific involvement of coenzymes(and prosthetic groups) in binding andcatalyzing the substrate explains their
activation of enzymic reactions. The majority of coenzymes are
synthesized from vitamins.
That is why we can use vitamins toincrease the metabolism of severalsubstances in the organism.
7/30/2019 1 Regulation of Enzymic Activity
7/44
7/30/2019 1 Regulation of Enzymic Activity
8/44
1) Metal ions,
2) coenzymes (or prosthetic groups),
3) vitamins (as precursors of
coenzymes),4) substrates can be used in practice
as agents for activating the
enzymes.
7/30/2019 1 Regulation of Enzymic Activity
9/44
Allosteric activation
The number of activators
influence allosteric center
(allosteric activators).
These are different products
of metabolism in cells.
7/30/2019 1 Regulation of Enzymic Activity
10/44
Inhibition of enzymes.
The majority of inhibitors are divided into:reversible and irreversible inhibitors.
Inhibitors
Reversible
Competitive Noncompetitive
Irreversible
7/30/2019 1 Regulation of Enzymic Activity
11/44
If the enzyme restores its activity after
removal of inhibitor, it is reversible
inhibitor(otherwise this is irreversible
inhibitor).
Irreversible inhibitors are tightly
bound to enzyme (by covalentbonds), and after dialysis, the activity ofenzyme is not restored.
I ibl i hibit f h li t
7/30/2019 1 Regulation of Enzymic Activity
12/44
Irreversible inhibitor of cholinesterase -Diisopropyl fluorophosphate (DFP)belonging to the class of so-called nervepoisons results in the complete inhibition of theactive center of cholinesterase.
Acetylcholine is an ester of acetic acid andcholine. It is a mediator in transmission ofnervous impulses.
Cholinesterase is an enzyme that catalyzesthe hydrolysis of acetylcholine to cholineand acetic acid.
Choline esteraseAcetylcholine + H2O choline + acetic acid
7/30/2019 1 Regulation of Enzymic Activity
13/44
DFP reacts with the OH group of serine
residue of the active center (of
cholinesterase) .
As the result acetylcholine is accumulatedand the transmission of nerve impulses is
impaired.
Active OH + F P = O inactive enzyme O P = Oenzyme
OCH(CH3)2 HF OCH(CH3)2
OCH(CH3)2 OCH(CH3)2
7/30/2019 1 Regulation of Enzymic Activity
14/44
Reversible competitive inhibition
Competitive inhibition is the enzymicreaction retardation produced by bindingthe enzyme active center with an inhibitorstructurally related to the substrate andcapable of preventing the formation of anenzyme-substrate complex.
Under competitive inhibition conditions,the inhibitor and the substrate, beingstructurally related species, compete forthe active center of enzyme.
E + S ES E +I EI
7/30/2019 1 Regulation of Enzymic Activity
15/44
The competing compound present in
excess binds preferably to the active
center. The enzyme becomes bound
either to the substrate, or to the inhibitor.
A ternary complex ESI (enzyme-
substrate-inhibitor) is never
formed, which is a distinctive feature ofthis type of inhibition.
7/30/2019 1 Regulation of Enzymic Activity
16/44
The inhibition occurs as substrate-like inhibitors bind a
certain member of enzyme molecules, leading toincapability of forming an enzyme-substrate complex.
Therefore, competitive inhibitorinfluences the binding of the
substrate with the enzyme. The distinctive sign of competitive inhibition: the
removal of inhibitory blocking can
be accomplished by an excess ofthe substrate whose molecules eliminate theinhibitor from the active center of the enzyme moleculesand reactivate the latter to catalytic activity.
7/30/2019 1 Regulation of Enzymic Activity
17/44
Inhibition of succinatedehydrogenase is an example of
competitive inhibition. For succinate dehydrogenase (SDH),
succinate is a natural substrate, while
the structurally related oxaloacetate (anintermediate in the Krebs cycle),
exhibits a competitive inhibitory action.
Succinate fumarate oxaloacetate malonate
FAD FADH2
SDH (Inhibitor) (inhibitor)
7/30/2019 1 Regulation of Enzymic Activity
18/44
Effect of a competitive inhibitor.
7/30/2019 1 Regulation of Enzymic Activity
19/44
In presence of inhibitor the rate of reaction
will decrease, but we can remove the
inhibition by an excess of substrate. E + S ES
E + I EI
EI + S ES + I That is why, the value of Vmax in case of
competitive inhibition (VmaxI), doesnt
change. But Km increases. Because this inhibitor
affects the affinity of enzyme for substrate.
7/30/2019 1 Regulation of Enzymic Activity
20/44
Noncompetitive inhibition of
enzymes is the retardation associatedwith the effect of an inhibitor on thecatalytic conversion rather than on the
substate-enzyme binding.
A noncompetitive inhibitor either directly
binds the catalytic groups of theenzyme active centeror, on binding withthe enzyme, leaves the active center free
and induces conformation changes in it.
7/30/2019 1 Regulation of Enzymic Activity
21/44
Noncompetitive inhibition peculiarity The conformational changes affect the
structure of the catalytic site andprevent its interaction with the substate.
Since the noncompetitive inhibitor exhibits
no effect on the substrate binding, in thiscase (as distinct from competitive
inhibition) formation of a ternary
complex ESI (E+S+IESI) is observed. However, no conversion of this complex to
any reaction products occurs.
Heavy metal ions and their organic
7/30/2019 1 Regulation of Enzymic Activity
22/44
Heavy metals act as noncompetitive inhibitors only when
taken in small concentrations. Taken in excess, they act
as inactivators, or denaturants (this denaturation).
Heavy metal ions and their organiccompounds belong to noncompetitiveinhibitors of enzymes. For this reaction, theions of heavy metals (mercury, lead, cadmium,
arsenic and some others) are very toxic. For example, they can block the S-H
groups that make part of the catalyticsite of an enzyme. We cannot remove thisinhibitor by means of the increase of substrateconcentration, only with the help of compoundscalled reactivators.
EI + reactivator E + reactivator + I
7/30/2019 1 Regulation of Enzymic Activity
23/44
Effect of a noncompetitive inhibitor.
7/30/2019 1 Regulation of Enzymic Activity
24/44
Application of inhibitors in medicine. In therapy, noncompetitive inhibitors (mercury-,
arsenic-, and bismuth-containing preparations)
are used that are capable of noncompetitivelyinhibiting enzymes in the organism cells or in thecells of pathogenic bacteria, which actuallydetermines the medical effects of thesepreparations.
A number of preparations, such as neostigminemethylsulphate, physostigmin and sevine,depress reversibly the enzyme (choline esterase(CE)). They are competitive inhibitors.
Their action is associated with accumulatedacethylcholine. But as they are reversibleinhibitors, their effect subside gradually, since themore of acethylcholine is accumulated, the faster iteliminates the inhibitor from the active center of
choline esterase.
7/30/2019 1 Regulation of Enzymic Activity
25/44
Sulphanilamides are used for
treatment of certain infectiousdiseases caused by bacteria.
In bacteria para-aminobenzoic acid is
used for the synthesis of folic acid (the
folic acid is the factor of growth for
bacteria).
Owing to the structural congenerity,
sulphanilamide blocks reaction of folic acid
synthesis, leading to the inhibition of
bacterial growth
7/30/2019 1 Regulation of Enzymic Activity
26/44
For humas folic acid is a vitamin. It is notsynthesized in the organism.
That is why, sulphanilamides do noteffect the human cells.
To create the saturation, and to eliminate p-
aminobenzoic acid from the enzyme inbacteria, first we must use the large dose
(several tablets at once). And then to
prevent metabolism of the drug and itssecretion out of the organism we must use
the usual doses.
7/30/2019 1 Regulation of Enzymic Activity
27/44
Application of irreversible inhibitors
The toxicity of irreversible inhibitors ofCE (the excess of acethylcholine
poduces a toxic action on the organism)
is by far superior. For this reason they are widely used
against pests, domestic vermins and
rodents (for example, chlorophos), andas warfare gases (sarin and tabun).
7/30/2019 1 Regulation of Enzymic Activity
28/44
Regulation of enzymic activity.
Allosteric regulation of enzymic
activity.
7/30/2019 1 Regulation of Enzymic Activity
29/44
The allosteric regulation is characteristiconly a special group of enzymes with
quaternary structure possessing regulatorycenters for binding allosteric effectors.
Regulation
Covalent Allosteric(with the help ofallosteric site)
a)chemical modificationb)activation of zymogens
That is why distinctive properties of allosteric
7/30/2019 1 Regulation of Enzymic Activity
30/44
That is why, distinctive properties of allostericenzymes are:
1) They have quarternary structure, consist of 2and above subunits.
2) They have allosteric center (some of theenzymes may possess several allostericcenters).
3) They do not have hyperbolic shape on the
graph of Michaelis-Menten.V simple enzyme
allosteric
enzyme
[S]
7/30/2019 1 Regulation of Enzymic Activity
31/44
They have characteristicsigmoidal curve (as in case ofhemoglobin saturation withoxygen). Because the activecenters of enzyme subunitsfunction cooperatively .
The affinity of every next activecenter for substrate is defined bythe saturation degree of thepreviously involved centers.
7/30/2019 1 Regulation of Enzymic Activity
32/44
Coordinated functioning of the centers
depends on allosteric effectors.
The mechanism of action of an allostericinhibitor on enzyme is effected via a changeof the enzymes active center conformation.The observed decrease of enzymic reaction rate
is due either to an increase in Km, or to adecrease in the maximal reaction rate (Vmax).
An allosteric activator, on the contrary,facilitates the conversion of the substrate inthe active center of enzyme, which isaccompanied either by a decrease in Km, or byan increase in the maximum rate Vmax.
The majority of enzymes in the cell are allosteric.They take a keyposition in metabolism.
7/30/2019 1 Regulation of Enzymic Activity
33/44
Allosteric enzyme can be regulated by thesystem of negative feed-back (inhibition of theinitial enzyme I the conversion chain by the endproduct).
In such a manner the first enzyme in the reactionchain is switched off as the end productconcentration increases. Such enzyme (E1) is
called heterotropic (because the substrate Aand allosteric effector (D)) are differentsubstances.
When the substrate serves as positiveeffector (allosteric activator)ABCD suchenzyme is called homotropic.
If the enzyme has both regulation it is calledhomoheterotropic.
7/30/2019 1 Regulation of Enzymic Activity
34/44
Covalent regulation
The activation of certain enzymes can beaccomplished via structural modifications
non in the active center. It can be:
1) the activation of an inactive precursorrefered to as proenzyme, or zymogen(Activation of zymogens).
2) the activation via addition of a specificmodifying group to the enzymemolecule (chemical modification).
A ti ti f
7/30/2019 1 Regulation of Enzymic Activity
35/44
Activation of zymogensExample digestive enzymes. The conversion of
inactive precursor (proenzyme, zymogen)
takes place by means of proteolysis.
S +
HCl in the stomach
autolytic pepsin action
pepsinogen pepsin
peptide, which
prevents the
interaction of S
with active
center
Trypsinogen trypsinChymotryp-sinogen
chymotrypsin(in the smallintestine)
enteropeptidase
7/30/2019 1 Regulation of Enzymic Activity
36/44
This is non reversible process.
For what purpose these enzymes aresynthesized firsty in inactive form?
The pancreatic production of trypsin (and ofother proteinases) in an inactive form has adefinite biological sense, since otherwise typsin,produced in its active form, could inflict adestructive proteolytic action both on thepancreatic cells and on the enzymessynthesized by pancreas (amylase, lipase and
others). These enzymes exhibit relative group substratespecificity. They are specific towards the peptidebonds and catalyze proteolysis of variousproteins and also proteins of pancreas itself.
E l f h i l difi ti )
7/30/2019 1 Regulation of Enzymic Activity
37/44
Example of chemical modification)
This is reversible process. This is
regulation by means of reversible
chemical modification. The chemical modification can involve
methylation, glycosylation (of course
phosphorylation) and other reactions.
Einactive Eactive(phosphorylase B) (phosphorylase A)protein kinase
H3PO4H2O
protein
reactions ofphosphorylation
and dephosphorylation.
ATPADP
7/30/2019 1 Regulation of Enzymic Activity
38/44
Multienzyme systems.
Each cell in the organism possesses its specific
set of enzymes. And each organell has specific
set of enzymes. That is why, each enzyme has
the definite localization in the cell, and functionsin the definite compartment of the cell. These
compartments are separated by the membranes
(for example mitochondria).
The enzyme cannot go out of this compartmentand functions their. Compartmentalization is a
distinctive feature of enzyme catalysis.
7/30/2019 1 Regulation of Enzymic Activity
39/44
For example, the breakdown of fatty acidstaked place in mitochondria, but theirsynthesis in cytoplasm. These processesare separated in the cell by means ofcompartmentalization of enzymes.Otherwise, the effect of conversions wouldbe equal to zero.
7/30/2019 1 Regulation of Enzymic Activity
40/44
In the cell, each enzyme performs its function
not independently, but rather in a closecooperation with other enzymes. Thus,
functionally interdependent individual
enzymes, compose multienzyme systems, or
complexes. There are
1) functional
2) structure-functional
3) combined types of multienzyme systemorganization.
7/30/2019 1 Regulation of Enzymic Activity
41/44
The functional organization is remarkable in thatthe individual enzymes are united in a function-
oriented multienzyme system through theagency of metabolites that are capable ofdiffusing from one enzyme to another.
In a functionally organized multienzyme system,
the reaction product of the first enzyme in theconversion chain serves as a substrate for thesecond enzyme. Glycolysis serves as anexample for functional organization of
multienzyme systems. All of the glycolysis enzymes persist in a state of
dissolution. Each reaction is catalyzed byindividual enzymes.
7/30/2019 1 Regulation of Enzymic Activity
42/44
The structure-functional organization consists inthat the enzymes form structural functon-oriented systems via enzyme-enzyme (protein-potein) interactions. In such a manner, structuralmultienzyme supermolecular complexes arebuilt up.
For example, pyruvate dehydrogenasemultienzyme complex composed of severalenzymes engaged in the oxidation of pyruvicacid or structurally related enzymes involved in acommon function, the synthesis of fatty acids.
Such multienzyme complexes are tightly boundand resist decomposition into constituentenzymes. This is their major distinction fromfunctionally organized multienzyme systems.
7/30/2019 1 Regulation of Enzymic Activity
43/44
Enzymes also may become fixed on thebiomembrane to form a chain. This is anexample for the mitochondrial respiratory chain
involved in energy generation and transport ofelectrons and protons. A separation of enzymesconstitutive of such systems puts an end to theiractivity.
The combined type of multienzyme systemoganization is a combination of the two abovetypes i.e. one part of the multienzyme systemhas a structural, and the other one, a functionalorganization.
The example is the multienzyme system ofKrebs cycle in which some of the enzymes areunited into a structural complex (2-oxoglutaratedehydrogenase complex), while other enzymesare functionally interrelated through metabolite
mediators.
7/30/2019 1 Regulation of Enzymic Activity
44/44
Practical use of enzymes. In the enzymes and isozymes have the
diagnostic importance to identify the affectedorgan. Digestive enzymes (pepsin, trypsin,etc.)are used as a substitutes for a deficient enzymein the organism.
Immobilized enzymes are used in thetechnological sysntheses of a number ofhormonal preparations, in high-sensitiveanalyses of drugs. Proteolytic enzymes (trypsinand chymotrypsin), immobilized on gauze
bandages or tampons, are used in surgery forcleansing purulent wounds and necrotic tissues.
Their action consists in enzymic degradation ofdead cell proteins discharged in purulentwounds.